Variability of cardiac rhythm in the case of elderly patients who underwent coronary angiostenting against the background of acute coronary syndrome

O.P. Esina, S.G. Esin, V.P. Nosov, L.Yu. Koroleva, G.V. Kovaleva
Keywords: heart rate variability, coronary artery stenting, elderly.
Medicinskij al'manah, 2017, issue 3, pages 176-179.

To evaluate heart rate variability (HRV) in elderly patients after acute coronary syndrome (ACS), having

undergone coronary angioplasty and stenting. All patients taking anticoagulants and antiplatelet drugs

received standard combined medical anti-ischemic and antihypertensive therapy, which included selective

beta-blockers and / or slow calcium channel blockers and / or angiotensin converting enzyme inhibitors

and /or angiotensin receptor blockers, and / or thiazide diuretics, as well as statins. 24-hour ECG monitoring

with evaluation of HRV was performed in all hospitalized patients on day +2 +3 after coronary stenting.

In elderly patients, who underwent coronary stenting in ACS, low HRV prevalence was noted in early hospital

period, even with adequate conservative therapy. The significant predominance of humoral and metabolic

influences on HRV may be a reason to intensification of therapy by angiotensin-converting enzyme

inhibitors or angiotensin receptor blockers in elderly hypertensive patients with ACS without ST-segment

elevation taking into account the values of blood pressure.

1. Bokeriya L.A., Bokeriya O.L., Volkovskaya I.V. Variabel'nost' serdechnogo

ritma: metody izmereniya, interpretaciya, klinicheskoe ispol'zovanie. Annaly

aritmologii. 2009. № 4. C. 21-35.

2. Profilaktika serdechno-sosudistyh zabolevanij v klinicheskoj praktike.

Rekomendacii Evropejskogo obshchestva kardiologov (peresmotr 2012 g.).

Rossijskij kardiologicheskij zhurnal. 2012. T. 4. № 96. Prilozhenie 2. 84 s.

3. Cannon C.P., Brindis R.G., Chaitman B.R. et al. ACCF/AHA key data elements

and definitions for measuring the clinical management and outcomes of patients

with acute coronary syndromes and coronary artery disease: a report of the

American College of Cardiology Foundation /American Heart Association Task

Force on clinical data standards (writing committee to develop acute coronary

syndromes and coronary artery disease clinical data standards). J. Am. Coll. Cardiol.

2013. Vol. 61. № 9. P. 992-1025.

4. ESC/EACTS Guidelines on myocardial revascularization. The Task Force on

Myocardial Revascularization of the European Society of Cardiology (ESC) and the

European Association for Cardio-Thoracic Surgery (EACTS). Developed with the

special contribution of the European Association of Percutaneous Cardiovascular

Interventions (EAPCI). Eur. J. Cardiothorac. Surg. 2014. Vol. 46. № 4. P. 517-592.

5. Weiss E.S., Chang D.D., Joyce D.L. et al. Optimal timing of coronary artery

bypass after acute myocardial infarction: a review of California discharge data. J

Thorac Cardiovasc Surg. 2008. Vol. 135 (3) P. 503-511.

6. Sabate M., Cequier A., Iniguez A., et al. Everolimus-eluting stent vs. baremetal

stent in ST-segment elevation myocardial infarction (EXAMINATION): 1

year results of a randomised controlled trial. Lancet. 2012. Vol. 380 (9852).

P. 1482-1490.

7. Sabate M., Raber L., Heg D. et al. Comparison of Newer-Generation Drug-

Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation

Myocardial Infarction: A Pooled Analysis of the EXAMINATION (clinical Evaluation

of the Xience-V stent in Acute Myocardial INfArc-TION) and COMFORTABLE-AMI

(Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal

Stents in Acute ST-Elevation Myocardial Infarction) Trials. JACC Cardiovasc. Interv.

2014. Vol. 7 (1). P. 55-63.

8. Kristensen S.D., Laut K.G., Fajadet J., et al. Reperfusion therapy for ST

elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

Eur. Heart J. 2014. Vol. 35. P. 1957-1970.

9. Cavender M.A., Milford-Beland S., Roe M.T. et al. Prevalence, predictors, and

in-hospital outcomes of non-infarct artery intervention during primary

percutaneous coronary intervention for ST-segment elevation myocardial infarction

(from the National Cardiovascular Data Registry). Am. J. Cardiol. 2009. Vol. 104 (4).

P. 507-513.

10. Hamm C.W., Bassand J.P., Agewall S., et al. Guidelines ESCCfP. ESC

Guidelines for the management of acute coronary syndromes in patients presenting

without persistent ST-segment elevation: The Task Force for the management of

acute coronary syndromes (ACS) in patients presenting without persistent

ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart. J.

2011. Vol. 32 (23). P. 2999-3054.

11. Buccelletti E., Gilardi E., Scaini E., et al. Heart rate variability and myocardial

infarction: systematic literature review and metanalysis. Eur. Rev. Med. Pharmacol.

Sci. 2009. Vol. 13 (4). P. 299-307.

12. Ryabykina G.V., Sobolev A.V. Variabel'nost' ritma serdca. M.: Overlej,

2000. 200 s.

13. Carpeggiani C., L’Abbate A., Landi P., et al. Early assessment of heart rate

variability is predictive of in-hospital death and major complications after acute

myocardial infarction. Int. J. Cardiol. 2004. Vol. 96 (3). P. 361-368.

14. Kotecha D., New G., Flather M.D., Eccleston D., Pepper J., Krum H. Fiveminute

heart rate variability can predict obstructive angiographic coronary disease.

Heart. 2012. Vol. 98 (5). P. 395-401.

15. Stein P.K., Barzilay J.I., Chaves P.H., et al. Novel measures of heart rate

variability predict cardiovascular mortality in older adults independent of traditional

cardiovascular risk factors: the Cardiovascular Health Study (CHS). J. Cardiovasc.

Electrophysiol. 2008. Vol. 19 (11). P. 1169-1174.

O.P. Esina, S.G. Esin, V.P. Nosov, L.Yu. Koroleva, G.V. Kovaleva Variability of cardiac rhythm in the case of elderly patients who underwent coronary angiostenting against the background of acute coronary syndrome. Medicinskij al'manah 2017; (3): 176–179, http://dx.doi.org/10.21145/2499-9954-2017-3-176-179